Digital Pathology Market Report | Size & Share 2028

Digital Pathology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Scanners, Software, Storage, and Communication Systems), Type (Human Pathology and Veterinary Pathology), Application (Drug Discovery, Disease Diagnostics, Teleconsultation, and Training & Education), and End User (Pharma and Biotech Companies, Hospitals, and Academics) 

Publication Month : Aug 2022

  • Report Code : TIPHE100000855
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 226
Inquire Before Buy



[Research Report] The digital pathology market is expected to grow from US$ 952.62 million in 2022 to US$ 1,892.40 million by 2028; it is estimated to grow at a CAGR of 12.1% from 2022 to 2028.

Market Insights and Analyst View:

Digital pathology includes the acquisition, management, sharing, and interpretation of pathology information, which includes slides and data in a digital environment. A digital slide image file is generated, allowing for high-resolution viewing, interpretation, and image analysis of digital pathology slides. Digital pathology allows pathologists to engage, evaluate, and collaborate rapidly and remotely, with transparency and consistency, thus improving efficiency and productivity. The future of digital pathology could eventually encompass enhanced translational research, computer-aided diagnosis (CAD), and personalized medicine. Digital pathology offers benefits not easily achieved with glass slides alone, such as improved analysis and reduced errors.One of the significant benefits of digital pathology is the many ways it improves productivity in the short and long term.

Growth Drivers and Challenges:

Periodic diagnosis is the first step of every cancer treatment. With the help of the traditional pathology services, one can only understand where the tumors cells are located; this makes it difficult to share the cases for a second review. The use of digital pathology allows the in-depth diagnosis of tumors. The digital pathology procedure for cancer diagnosis typically involves scanning conventional glass slides and, after digitally uniting successive images into a single, whole image that replicates the information on the glass slide. The pictures are clubbed with associated clinical/hospitals or labs to provide pathologists with an integrated picture of each unique cancer condition. In April 2017, Philips received an FDA clearance to market the Philips IntelliSite Pathology Solution for primary diagnostic use in the US. With the continuously growing number of cancer cases, the complexity and number of tests are increasingly simultaneously. The Philips IntelliSite Pathology Solution facilitates automated digital pathology via image creation, viewing, and management systems, among others, featuring ultrafast pathology slide scanner, among other features of the scanner. Similarly, in January 2021, Roche launched the CE-IVD automated digital pathology algorithms, capable of uPath HER2 Dual ISH image analysis and uPath HER2 (4B5) image analysis for breast cancer diagnosis, which also helps healthcare providers determine the best treatment strategy for each patient. Artificial intelligence is used in image analysis algorithms to assist pathologists in achieving quick and accurate patient diagnoses of breast cancer. Thus, technological developments in the cancer diagnostics are boosting the digital pathology market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Digital Pathology Market: Strategic Insights

Market Size Value inUS$ 952.62 Million in 2022
Market Size Value byUS$ 1,892.40 Million by 2028
Growth rateCAGR of 12.1% from 2022 to 2028
Forecast Period2022-2028
Base Year2022
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The “Global Digital Pathology Market” is segmented based on product, type, application, end user, and geography. Based on product, the digital pathology market is segmented into scanners, software, communication system, and storage. Based on type, the digital pathology market is bifurcated into human pathology and veterinary pathology. Based on application, the digital pathology market is segmented into teleconsultation, disease diagnosis, drug discovery and training & education. Based on end user, the digital pathology market is segmented into pharma & biotech companies, hospitals, and academic. The digital pathology market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

Based on product, the digital pathology market is segmented into scanners, software, storage, communication. The scanners segment held the largest share of the market in 2021, also the same segment is anticipated to register the highest CAGR of 12.3% in the market during the forecast period. Scanners help in producing quick, reliable, and high-resolution images of cells. It helps pathologists, histologists, and other medical professionals scan slides and upload the images on the network for remote access and to collaborate with peers. The scanners provide automated cellular imaging for fixing cell assays and fluorescence, phase contrast and transmit light. The technological advancement has added integrated software along with the scanners for further analysis, edit, manage, and share virtual slides. For instance, in April 2021, Optra scan, the leading end-to-end digital pathology solution provider, launched OS-ultra 320 the world’s first-ever affordable high-speed digital pathology scanner.

The pathology imaging system uses the new scanner technology and software for pathological exams to digitise the slides. It has replaced the standard slides and microscope pathology workflow. Pathologists can examine high-quality digital photographs of the pathology workflow with the assistance of precision instruments by digitising slides. This system can store images in a computer, improving the pathology workflow. Thus, the pathology imaging system market is expected to grow.

Digital Pathology Market, by Product – 2022 and 2028

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Based on type, the digital pathology market is segmented into human pathology and veterinary pathology. The human pathology segment is anticipated to hold the largest market share of 65.94% in 2022 and is expected to register the highest CAGR of 12.5% during the forecast period. The major driving factors for the growth of the human pathology segment are the increasing number of cancer research activities and growing collaborations among research institutes, universities, and pathology laboratories. Human Pathology is delineated to bring information of clinicopathologic significance to human disease to the laboratory and clinical physician. It represents information drawn from morphologic and clinical laboratory studies with direct applicability to understanding human diseases. It covers every aspect of patient care, from diagnostic testing and treatment advice to using cutting-edge genetic technologies and preventing disease.

Based on application, the digital pathology market is segmented into teleconsultation, disease diagnosis, drug discovery and training & education. In 2021, the drug discovery segment is likely to hold the largest share of the market, and same segment is expected to grow at the fastest rate during the coming years. The advantages of digital pathology are not just restricted to improved speed and accurate results, but it also allows pathologists to present their expertise over geographic distances but also to pharmaceutical and biotechnological companies. The biotechnology and pharmaceutical companies always face problems with reviewing and analyzing thousands of slides in a preclinical study, digital pathology automates image analysis, provide instant and intelligent access to unmanageable amounts of histopathologic data to speed the discovery process ultimately. The researchers in companies can view digital slides on internet for vast improvement over current single field of view image viewing approaches.

Based on end users, the digital pathology market is segmented into pharma & biotech companies, hospitals, and academics. The pharma & biotech companies’ segment is likely to hold the largest share of the market in 2021 however, the recombinant vaccines segment is anticipated to register the highest CAGR of 12.5% of the market during the forecast period. Pharmaceutical and biotechnology companies are taking initiatives to manage their work digitally; the companies are constantly engaged in discovering molecules and biomarkers for drugs or therapies. Digital pathology aids in transforming global pharmaceutical research by enabling data sharing to pharmaceutical companies and R&D labs. These companies evaluate drugs by collecting and analyzing data with the help of patient’s conditions. Digital pathology solution helps these companies to maintain records and for effective workflow management of the workflow. For instance, companies such as Agilent Technologies, Genentech are partnering with AI companies to upgrade their process such as digitization of their pathology labs and advanced therapy production.

Regional Analysis:

Based on geography, the digital pathology market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. North America is likely to capture a significant share of the global market in 2021, owing to the increasing burden of chronic diseases, the growing adoption of technologies in chronic disease management, rising investments, increasing product launches, and initiatives the market leaders take. The US is expected to grow significantly during the forecast period. The growing cases of chronic diseases such as cancer, Alzheimer's disease, and others are anticipated to propel the digital pathology market. For instance, the American Cancer Society 2022 report estimated that around 2,36,740 new cases of lung cancer will be diagnosed in the US in 2022. The same source also stated that 79,000 new cases of kidney cancer will be reported in 2022. Furthermore, the International Diabetes Federation (IDF) report in December 2021 estimated that 14 million adults in Mexico were living with diabetes in 2021. Also, as per a press release by the government of Canada published in August 2021, diabetes is the major chronic disease affecting Canadians, where over 3 million Canadians and 6.1% of Canadian adults were at high risk of developing diabetes as of August 2021. The high burden of cancer is expected to boost the demand for digital pathology, thereby driving market growth.

Europe is the second leading region in the global cell development market. Germany is holding the largest share in the Europe digital pathology market during the forecast period due to the factors such as the increase in the support for the digital pathology projects, education, and training programs in France, rising cancer prevalence and adoption of digital pathology solution in UK and increasing number of conferences in Germany are likely to boost the growth of digital pathology market in Europe are the factors fueling the growth of digital pathology market in Europe.

Industry Developments and Future Opportunities: 

Various initiatives taken by key players operating in the global digital pathology market are listed below:

  1. In June 2022, SpIntellx, Inc., and Inspirata collaborated to integrate the SpIntellx HistoMapr-Breast platform and Inspirata’s Dynamyx software into a seamless solution. HistoMapr-Breast is the only computational pathology software that taps the power of explainable artificial intelligence (xAI) for healthcare providers to diagnose, prognosticate and treat breast cancer more accurately and efficiently.
  2. In June 2022, Roche got CE-IVD approval, marking the next-generation Ventana DP 600 slide scanner for digital pathology.
  3. In May 2020, Danahar (Leica Biosystems) launched the Aperio GT 450 DX, its next generation digital pathology scanner, in the APAC region. With continuous loading, no-touch operation, and 32 second scan time at 40x magnification, the Aperio GT 450 DX, registered as CE IVD and TGA, allows healthcare organizations to scale up digital pathology so they can meet ever-increasing demands without sacrificing quality.
  4. In July 2020, three key members of 3DHISTECH’s PANNORAMIC scanner range, PANNORAMIC 250 Flash III, PANNORAMIC Scan II and PANNORAMIC Midi II as well as their control software have been upgraded to even better serve the diverse needs of cancer and pharmaceutical research, molecular and developmental histology, neuroscience and many more.
  5. In August 2020, Danahar (Leica Biosystems), a global leader in pathology workflow solutions, announced the European launch of its Aperio GT 450 DX digital pathology scanner. This next generation imaging system was unveiled at the highly successful Leica Biosystems Digital Pathology Virtual Summit and is already installed at the Centre of Excellence at Leeds Teaching Hospitals NHS Trust NHS, UK.
  6. In October 2020, Indica Labs, announced the formal launch of an enterprise-wide, cloud-based deployment of Indica Labs’ software within the National Cancer Institute (NCI), including HALO, HALO AI, HALO Link and HALO AP. Accessible to hundreds of users within the NCI, managing millions of digital images, and facilitating the analysis of thousands of images daily, this is the largest single deployment of Indica Labs’ software world-wide.
  7. In May 2020, Danahar (Leica Biosystems), the global leader in pathology workflow solutions, and the international medical imaging IT and cybersecurity company, Sectra, announced a collaboration to seek a combined 510(k) clearance from the U.S. Food & Drug Administration (FDA) soon. The goal is for the integrated clinical digital pathology solution to address the clinical needs of enterprise level customers such as academic medical centers, clinical research organizations and large hospital networks.

Competitive Landscape and Key Companies:

Some of the prominent players digital pathology companies include Koninklijke Philips N.V., Nikon Corporation, Perkin Elmer, Inc., Indica Labs, 3DHISTECH Ltd., Danaher, Hamamatsu Photonics K.K., F. HOFFMANN-LA ROCHE LTD., Visiopharm A/S, and Glencoe Software, Inc among others. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their digital pathology market share.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Type, Application, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSAM, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions

What are digital pathology?

Digital pathology comprises the gaining, organizing, sharing, and interpretation of pathology information. The process involves converting the glass slides into digital pathology slides using digital pathology scanning solutions. A digital slide image file is then generated, which allows the high-resolution viewing, interpretation, and image analysis of digital pathology slides.

What are the driving factors for the global digital pathology market across the world?

The factors that are driving the growth of the digital pathology market are rising adoption of digital pathology to enhance lab efficiency and the growing applications of digital pathology in drug development and companion diagnostics.

What is the estimated digital pathology market size in 2022?

The digital pathology market is estimated to be valued at US$ 952.62 million in 2022.

Which segment by product type led the digital pathology market?

The scanner segment is expected to hold the largest share of the market in the global digital pathology market contributing a market share of 55.27% in 2021.

Which region is projected to be the fastest-growing region in the global digital pathology market?

The Asia Pacific is expected to be the fastest-growing region in the digital pathology market over the forecast period due to growing investments from international players in China and India, increasing disposable income, and growing cancer cases in these regions will show promising growth in the digital pathology market.

What is the market CAGR value of the digital pathology market during the forecast period?

The CAGR value of the digital pathology market during the forecasted period of 2022-2028 is 12.1%

What are the growth estimates for the digital pathology market till 2028?

The digital pathology market is expected to be valued at US$ 1892.40 million in 2028.

Who are the major players in the digital pathology market across the globe?

The digital pathology market majorly consists of the players, such as Koninklijke Philips N.V.; Nikon Corporation; Perkin Elmer, Inc.; Indica Labs; 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; F. Hoffmann-La Roche Ltd; Visiopharm A/S; Glencoe Software, Inc.; Danaher Corporation.

The List of Companies - Digital Pathology Market

  1. Koninklijke Philips N.V.
  2. Nikon Corporation
  3. Perkin Elmer, Inc.
  4. Indica Labs
  5. 3DHISTECH Ltd.
  6. Hamamatsu Photonics K.K.
  7. F. Hoffmann-La Roche Ltd
  8. Visiopharm A/S
  9. Glencoe Software, Inc.
  10. Danaher Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports